Skip to main content
medichelpline
Join Free
Back to Drug Index
General MedicationsORALGeneric

GRIFULVIN V

GRISEOFULVIN, MICROCRYSTALLINE

Standard Dose
125MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued

Key Takeaways

  • Primary indication: Marketing status: Discontinued
  • Approval overview GRIFULVIN V is listed in Drugs@FDA under application 050448 (NDA).
  • Marketing status: Discontinued Active ingredient GRISEOFULVIN, MICROCRYSTALLINE Form and strength SUSPENSION;ORAL - 125MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor JOHNSON AND JOHNSON Submission history Latest submission status date: 1998-10-08 00:00:00.

Structured Monograph

Clinical summary

Approval overview GRIFULVIN V is listed in Drugs@FDA under application 050448 (NDA). Marketing status: Discontinued Active ingredient GRISEOFULVIN, MICROCRYSTALLINE Form and strength SUSPENSION;ORAL - 125MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor JOHNSON AND JOHNSON Submission history Latest submission status date: 1998-10-08 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.